A Comparison of Azacitidine and Decitabine Activities in Acute Myeloid Leukemia Cell Lines

BACKGROUND: The cytidine nucleoside analogs azacitidine (AZA) and decitabine (DAC) are used for the treatment of patients with myelodysplastic syndromes and acute myeloid leukemia (AML). Few non-clinical studies have directly compared the mechanisms of action of these agents in a head-to-head fashio...

Descripción completa

Detalles Bibliográficos
Autores principales: Hollenbach, Paul W., Nguyen, Aaron N., Brady, Helen, Williams, Michelle, Ning, Yuhong, Richard, Normand, Krushel, Leslie, Aukerman, Sharon L., Heise, Carla, MacBeth, Kyle J.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2814859/
https://www.ncbi.nlm.nih.gov/pubmed/20126405
http://dx.doi.org/10.1371/journal.pone.0009001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2814859/
https://www.ncbi.nlm.nih.gov/pubmed/20126405
http://dx.doi.org/10.1371/journal.pone.0009001

Ejemplares similares